deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 8-arm NCT04450901

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

A Phase 1/2a, Open-Label, Multicenter, Single Arm, Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

Sponsor: Novotech (Australia) Pty Limited

Conditions Advanced Solid Tumors
Interventions YBL-006
Updated 9 times since 2020 Last updated: Dec 1, 2022 Started: Jul 1, 2020 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04450901, this PHASE1/PHASE2 trial focuses on Advanced Solid Tumors and remains ongoing. Sponsored by Novotech (Australia) Pty Limited, it has been updated 9 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Oct 2021 · 7 months · monthly snapshotRecruiting~Oct 2021 – ~Jan 2023 · 15 months · monthly snapshotRecruiting~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Jan 2025 — Sep 2025 [monthly]

    Unknown PHASE1/PHASE2

    Status: Active Not Recruiting → Unknown

  3. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Jan 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting · Phase: PHASE1 → PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Oct 2021 — Jan 2023 [monthly]

    Recruiting PHASE1

  2. Mar 2021 — Oct 2021 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2021 — Mar 2021 [monthly]

    Not Yet Recruiting PHASE1

  4. Jul 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Novotech (Australia) Pty Limited
  • Y Biologics Inc.
Data source: Y Biologics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations